Skip to content

Co-administration of Staphylococcus aures Fibronectin Binding Protein A N1-3 region and Lipoteichoic acid antigen mixture enhance antibody response in BALB/c mice

Sep 2026 · bioRxiv · 0 citations · 4 references
Biology

TL;DR

This study evaluated the efficacy of two surface antigens of S. aureus -fibronectin-binding protein A (FnBPA) and lipoteichoic acid (LTA) as vaccine candidates and highlighted the potential of a multi-antigen vaccine strategy for preventing S. aureus infections.

View source

Similar papers

Sep 2026

Intranasal immunization in mice with spore-associated serine-aspartate repeat-containing protein D from Staphylococcus aureus secreted in Bacillus subtilis

Findings demonstrate that B. subtilis can serve as an effective platform for recombinant protein secretion and mucosal antigen delivery, supporting its application in vaccine development against S. aureus infection via mucosal route.

Hoa T. T. Vo, V. K. Phạm, Kiet Ngo et al. · 0 citations
#protein folding Open access Sep 2026

An intranasal bivalent vaccine induces antigen-specific humoral and Th1/Th17 cellular immunity and protects young and aged mice against MRSA and Pseudomonas aeruginosa skin and soft tissue infections

ABSTRACT Staphylococcus aureus (SA) and Pseudomonas aeruginosa (PA) are ESKAPE pathogens that are responsible for severe skin and soft tissue infections (SSTIs), particularly in the elderly and those with immunocompromising conditions. Rising rates of methicillin-resistant S. aureus (MRSA) and carbapenem-resistant PA h...

Suhrid Maiti, T. Lu, Zackary Dietz et al. · 0 citations
Open access Sep 2026

Development of a PapG–AcmA surface-associated antigen on Lactobacillus reuteri as a vaccine strategy against uropathogenic Escherichia coli

Urinary tract infections (UTIs) are highly prevalent across diverse populations, with uropathogenic Escherichia coli (UPEC) recognized as the leading cause, responsible for more than 85% of cystitis and acute pyelonephritis cases. Because bacterial attachment to the uroepithelium is the critical initial step in coloniz...

Meisam Akrami, M. Akrami, Amirhossein Amini et al. · 0 citations
Open access Sep 2026

A “loopless” subdomain of transferrin binding protein B can elicit a broadly cross-reactive humoral immune response targeting variants from both encapsulated and non-typeable Haemophilus influenzae

Haemophilus influenzae is a Gram-negative bacterium that causes pneumonia, otitis media, and invasive infections such as meningitis and bacteremia. A vaccine that confers protection against disease caused by H. influenzae serotype b is currently available and is highly effective, but infections caused by non-b serotype...

Nikolas F. Ewasechko, David M. Curran, Luisa Samaniego-Barrón et al. · 0 citations
Open access Sep 2026

A multi-epitope vaccine targeting Mycoplasma pneumoniae P1 adhesin and CARDS toxin confers synergistic protection by adhesion inhibition and toxin neutralization

Background Mycoplasma pneumoniae (Mp) remains a major cause of community-acquired pneumonia in children and adolescents, and no vaccine against this pathogen is currently available. This study designed and evaluated P1Tx, a novel multi-epitope vaccine candidate derived from the immunodominant regions of the P1 adhesin...

Peng-Xiao Feng, Rui Hu, Huan-Bing Long et al. · 0 citations
Open access Oct 2026

Isoleucine102 and tryptophan104 of the Staphylococcus aureus formyl peptide receptor-like 1 inhibitor (FLIPr) are critical for mouse Fcγ receptor binding and inhibition of neutrophil phagocytosis.

Staphylococcus aureus employs a diverse repertoire of immune evasion proteins to escape host defenses. Formyl peptide receptor-like 1 inhibitory protein (FLIPr) is a secreted staphylococcal factor that targets both chemoattractant receptors and Fc gamma receptors (FcγRs) to suppress leukocyte activation and antibody-de...

Chen-Yi Chiang, Chia-Yu Chi, Yun-Ju Lee et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.